Riboflavin 5-Phosphate (R5P).

Pyridoxine 5-phosphate oxidase requires FMN, which riboflavin-5-phosphate supplies, to make pyridoxal-5-phosphate. Riboflavin sits directly upstream of active B6.

MTHFR is a flavoprotein that needs FAD to produce methylfolate from the methylene form. Riboflavin status sets how well the folate cycle reaches its methyl end.

Flavoproteins pass electrons to and from NAD and NADP, and the tryptophan to NAD route needs an FAD-dependent monooxygenase. The two coenzymes work as a linked redox pair.

Flavin-dependent reductases release iron from ferritin and support its handling in the gut wall. Riboflavin status changes how well an iron dose is used.

Glutathione reductase uses FAD to return oxidised glutathione to its reduced form. Riboflavin is what keeps the glutathione pool recycling.

NAC supplies the cysteine for making glutathione while riboflavin powers the reductase that recycles it. One fills the pool, the other keeps it reduced.

Xanthine oxidase and aldehyde oxidase each carry both an FAD and a molybdenum cofactor in the same protein. Neither metal nor flavin works there without the other.

Electron transfer flavoprotein and its FAD-dependent dehydrogenase pass electrons from fatty acid oxidation into the coenzyme Q pool. Riboflavin and CoQ10 are consecutive carriers on that route.

Acyl-CoA dehydrogenases, the first enzymes of each beta-oxidation cycle, are FAD-dependent. Carnitine delivers the fatty acyl groups those flavoenzymes then work on.

Methionine synthase reductase is a flavoprotein that keeps cobalamin in its reduced, active state. Riboflavin therefore serves the B12 reaction as well as the folate one beside it.

Pyruvate and ketoglutarate dehydrogenase complexes need thiamine pyrophosphate at the first step and FAD at the dihydrolipoyl step. The two vitamins act within one multi-enzyme assembly.

Thioredoxin reductase and glutathione reductase are selenium and flavin enzymes respectively, working on the same cellular thiol pools. Riboflavin and selenium serve two arms of one reducing network.

Riboflavin kinase phosphorylates riboflavin to flavin mononucleotide, and FAD synthetase then adds AMP to make flavin adenine dinucleotide. Both reactions use a magnesium-ATP complex. Magnesium is therefore part of how the body makes its own flavin cofactors from riboflavin. This is settled enzymology and does not imply that adding magnesium raises flavin status.

The conversion of tryptophan toward niacin runs through kynurenine monooxygenase, an FAD-dependent enzyme. When flavin supply is low that step slows and the pathway shifts toward other kynurenine branches. So riboflavin status sits between tryptophan intake and how much niacin the body makes for itself. The relationship is biochemical and is measured through metabolite markers rather than clinical outcomes.

Part of the body's niacin comes from tryptophan, and the FAD-dependent kynurenine monooxygenase step is the gate on that route. Riboflavin therefore contributes to endogenous niacin supply. Direct dietary niacin bypasses the step. The two vitamins also work in tandem downstream, since flavin and nicotinamide cofactors hand electrons to each other in nearly every dehydrogenase reaction.

Dihydrolipoamide dehydrogenase, the E3 component shared by the pyruvate and alpha-ketoglutarate dehydrogenase complexes, is a flavoprotein: it carries FAD and regenerates oxidised lipoamide. Lipoic acid cannot cycle without that flavin-dependent step. This is why the two are described together in energy metabolism. It is mechanism, not a demonstrated combined effect in people.

Choline dehydrogenase, the mitochondrial enzyme that oxidises choline toward betaine, is FAD-dependent. Flavin supply therefore sits on the route by which choline becomes a methyl donor. It links riboflavin to one-carbon metabolism without riboflavin being a methyl donor itself. The step is textbook and needs no citation.

Betaine is the product of the FAD-dependent oxidation of choline, and its further demethylation to dimethylglycine and sarcosine runs through two more flavin-dependent dehydrogenases. Riboflavin therefore appears at three points on the betaine route. Supplemental betaine enters downstream of the first step. The relevance is that flavin status shapes how the body handles these methyl donors internally.

Sarcosine dehydrogenase and dimethylglycine dehydrogenase are both flavoproteins, and their reactions release glycine from the choline and betaine breakdown route while feeding one-carbon units to folate. Flavin supply is what lets those two enzymes turn over. This describes a metabolic connection, not an effect of taking the two together.

Glutathione reductase is an FAD-dependent flavoprotein and is what keeps glutathione in its reduced state. Reduced glutathione in turn supports the regeneration of oxidised vitamin C, which is one of the routes that restores tocopherol radicals. Riboflavin therefore sits upstream of the recycling chain rather than acting as an antioxidant itself. Glutathione reductase activity is also the classical laboratory marker of riboflavin status, which is a marker and not an outcome.

Flavin-dependent reductases such as glutathione reductase and thioredoxin reductase draw their electrons from NADPH, and the flavoproteins of the respiratory chain pass electrons received from NADH. Nicotinamide cofactors and flavin cofactors are two halves of the same electron transfer economy. Supplying one does not substitute for the other. The pairing is mechanistic context rather than a tested combination.

Fatty acid oxidation needs coenzyme A, built from pantothenic acid, to activate the fatty acid, and it needs FAD-dependent acyl-CoA dehydrogenases to run the first oxidation of each cycle. The two vitamins occupy adjacent positions in the same sequence. Neither compensates for a shortfall in the other. This is why they appear together in energy-metabolism formulations.

Riboflavin and its phosphate are strong photosensitisers: exposed to light in solution they generate excited species that accelerate the oxidation of sensitive co-ingredients, ascorbate among them. This is a stability issue in liquids and clear packaging, not an interaction inside the body. The practical response is opaque packaging and light protection. It is worth stating because the two are often combined in liquid B and C products.

Conversion of riboflavin into flavin mononucleotide and FAD is influenced by thyroid hormone status, since the kinase that performs the first step is thyroid-responsive. Iodine supply sits upstream of thyroid hormone production. The link is indirect and describes normal regulation of a conversion step. No claim about supplementing the two together is intended.